KMT2A
MOLECULAR TARGETlysine methyltransferase 2A
KMT2A (lysine methyltransferase 2A) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting KMT2A
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
About KMT2A as a Drug Target
KMT2A (lysine methyltransferase 2A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented KMT2A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
KMT2A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.